183 related articles for article (PubMed ID: 37330661)
1. Disruption of the Clock Component Bmal1 in Mice Promotes Cancer Metastasis through the PAI-1-TGF-β-myoCAF-Dependent Mechanism.
Wu J; Jing X; Du Q; Sun X; Holgersson K; Gao J; He X; Hosaka K; Zhao C; Tao W; FitzGerald GA; Yang Y; Jensen LD; Cao Y
Adv Sci (Weinh); 2023 Aug; 10(24):e2301505. PubMed ID: 37330661
[TBL] [Abstract][Full Text] [Related]
2. Tissue-type plasminogen activator-plasmin-BDNF modulate glutamate-induced phase-shifts of the mouse suprachiasmatic circadian clock in vitro.
Mou X; Peterson CB; Prosser RA
Eur J Neurosci; 2009 Oct; 30(8):1451-60. PubMed ID: 19811533
[TBL] [Abstract][Full Text] [Related]
3. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.
Guda K; Claffey KP; Dong M; Nambiar PR; Rosenberg DW
Mol Carcinog; 2003 May; 37(1):51-9. PubMed ID: 12720300
[TBL] [Abstract][Full Text] [Related]
4. Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cells.
Arnoletti JP; Albo D; Granick MS; Solomon MP; Castiglioni A; Rothman VL; Tuszynski GP
Cancer; 1995 Sep; 76(6):998-1005. PubMed ID: 8625226
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-1 promotes the transcriptional activation of plasminogen activator inhibitor type 1 in carcinoma-associated fibroblasts.
Zhu Y; Yin WL; Ba YF; Tian L; Gu ZQ; Zhang MS; Zhong CN
Mol Med Rep; 2012 Nov; 6(5):1001-5. PubMed ID: 22895748
[TBL] [Abstract][Full Text] [Related]
6. A dual role for ERK-1/2 in the regulation of plasmin activity and cell migration in metastatic NSCLC-H1299 cells.
Zeitlmayr S; Cami D; Selmani B; Gudermann T; Breit A
Arch Toxicol; 2023 Dec; 97(12):3113-3128. PubMed ID: 37712947
[TBL] [Abstract][Full Text] [Related]
7. Thrombospondin-1 and transforming growth factor beta-1 upregulate plasminogen activator inhibitor type 1 in pancreatic cancer.
Albo D; Berger DH; Vogel J; Tuszynski GP
J Gastrointest Surg; 1999; 3(4):411-7. PubMed ID: 10482694
[TBL] [Abstract][Full Text] [Related]
8. The plasminogen activator/plasmin system is up-regulated after acute necrotizing pancreatitis in human beings.
Friess H; Duarte R; Kleeff J; Fukuda A; Tang WH; Graber H; Schilling M; Zimmermann A; Korc M; Büchler MW
Surgery; 1998 Jul; 124(1):79-86. PubMed ID: 9663255
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen Activator Inhibitor-1 Protects Mice Against Cardiac Fibrosis by Inhibiting Urokinase-type Plasminogen Activator-mediated Plasminogen Activation.
Gupta KK; Donahue DL; Sandoval-Cooper MJ; Castellino FJ; Ploplis VA
Sci Rep; 2017 Mar; 7(1):365. PubMed ID: 28336948
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta1 inhibits tumor growth in a mouse melanoma model by down-regulating the plasminogen activation system.
Ramont L; Pasco S; Hornebeck W; Maquart FX; Monboisse JC
Exp Cell Res; 2003 Nov; 291(1):1-10. PubMed ID: 14597403
[TBL] [Abstract][Full Text] [Related]
11. PAI-1 deficiency reduces liver fibrosis after bile duct ligation in mice through activation of tPA.
Wang H; Zhang Y; Heuckeroth RO
FEBS Lett; 2007 Jun; 581(16):3098-104. PubMed ID: 17561000
[TBL] [Abstract][Full Text] [Related]
12. Glutathione restores collagen degradation in TGF-beta-treated fibroblasts by blocking plasminogen activator inhibitor-1 expression and activating plasminogen.
Vayalil PK; Olman M; Murphy-Ullrich JE; Postlethwait EM; Liu RM
Am J Physiol Lung Cell Mol Physiol; 2005 Dec; 289(6):L937-45. PubMed ID: 16258002
[TBL] [Abstract][Full Text] [Related]
13. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
[TBL] [Abstract][Full Text] [Related]
14. Soluble type II transforming growth factor-beta receptor attenuates expression of metastasis-associated genes and suppresses pancreatic cancer cell metastasis.
Rowland-Goldsmith MA; Maruyama H; Matsuda K; Idezawa T; Ralli M; Ralli S; Korc M
Mol Cancer Ther; 2002 Jan; 1(3):161-7. PubMed ID: 12467210
[TBL] [Abstract][Full Text] [Related]
15. PERIOD2 is a circadian negative regulator of PAI-1 gene expression in mice.
Oishi K; Miyazaki K; Uchida D; Ohkura N; Wakabayashi M; Doi R; Matsuda J; Ishida N
J Mol Cell Cardiol; 2009 Apr; 46(4):545-52. PubMed ID: 19168071
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic value of small molecule inhibitor to plasminogen activator inhibitor-1 for lung fibrosis.
Huang WT; Vayalil PK; Miyata T; Hagood J; Liu RM
Am J Respir Cell Mol Biol; 2012 Jan; 46(1):87-95. PubMed ID: 21852684
[TBL] [Abstract][Full Text] [Related]
17. MEK/ERK pathway mediates cell-shape-dependent plasminogen activator inhibitor type 1 gene expression upon drug-induced disruption of the microfilament and microtubule networks.
Samarakoon R; Higgins PJ
J Cell Sci; 2002 Aug; 115(Pt 15):3093-103. PubMed ID: 12118065
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen Activator Inhibitor Type I Controls Cardiomyocyte Transforming Growth Factor-β and Cardiac Fibrosis.
Flevaris P; Khan SS; Eren M; Schuldt AJT; Shah SJ; Lee DC; Gupta S; Shapiro AD; Burridge PW; Ghosh AK; Vaughan DE
Circulation; 2017 Aug; 136(7):664-679. PubMed ID: 28588076
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-binding protein-5 activates plasminogen by interaction with tissue plasminogen activator, independently of its ability to bind to plasminogen activator inhibitor-1, insulin-like growth factor-I, or heparin.
Sorrell AM; Shand JH; Tonner E; Gamberoni M; Accorsi PA; Beattie J; Allan GJ; Flint DJ
J Biol Chem; 2006 Apr; 281(16):10883-9. PubMed ID: 16505491
[TBL] [Abstract][Full Text] [Related]
20. Thrombospondin (TSP) and transforming growth factor beta 1 (TGF-beta) promote human A549 lung carcinoma cell plasminogen activator inhibitor type 1 (PAI-1) production and stimulate tumor cell attachment in vitro.
Albo D; Arnoletti JP; Castiglioni A; Granick MS; Solomon MP; Rothman VL; Tuszynski GP
Biochem Biophys Res Commun; 1994 Sep; 203(2):857-65. PubMed ID: 8093068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
